Cardioprotective effects of dipeptidyl peptidase-4 inhibitors versus sulfonylureas in addition to metformin: A nationwide cohort study of patients with type 2 diabetes
Jui Wang, Hon‐Yen Wu, Kuo‐Liong Chien
Topics & Concepts
SitagliptinMedicineMaceSaxagliptinInternal medicineMyocardial infarctionVildagliptinMetforminDipeptidyl peptidase-4 inhibitorHeart failureType 2 diabetesDiabetes mellitusCardiologyCohortEndocrinologyInsulinPercutaneous coronary interventionDiabetes Treatment and ManagementHeart Failure Treatment and ManagementPeptidase Inhibition and Analysis